Clinical Decision Support Disclaimer

MedEazy is clinical decision support software intended to present advisory information — including drug reference, interaction checks, allergy and contraindication signals, dosing and monitoring prompts, stewardship cases, and related evidence — for review by qualified healthcare professionals.

It is not intended to replace professional judgment, the authoritative electronic health record, independently verified drug information sources, direct patient assessment, or mandatory clinical, pharmacy, or governance review required by your institution.

MedEazy does not autonomously diagnose conditions, prescribe medications, dispense drugs, administer treatment, or make final clinical decisions on behalf of any clinician or patient.

Licensed prescribers, pharmacists, nurses, and other authorized users remain solely responsible for verifying information, assessing patient-specific context, interpreting outputs, and documenting decisions in the medical record according to hospital policy and applicable professional standards.

Users must not rely on MedEazy as the sole basis for critical decisions when patient-specific data is incomplete, stale, contradictory, or when the interface displays uncertainty, missing inputs, or degraded integration states.

Patient-specific outputs should expose, where applicable:

• The basis for the signal (rule, monograph section, protocol, or approved source reference).
• Input data used and its freshness or last-updated time.
• Content or rule version and review date.
• Severity, clinical significance, evidence level, and recommended action.
• Explicit uncertainty, withheld checks, or unavailable integrations.

Drug knowledge reflects licensed content, tenant configuration, and published rule packages at a point in time. It may not include every local product, compounding formulation, traditional medicine, or off-label use relevant to your patient.

Interaction and safety checks are deterministic within defined rule scope. They cannot account for all clinical nuance, rare idiosyncratic reactions, or information not present in connected systems.

Where enabled, AI assists natural-language retrieval and explanation over approved, versioned content with citations. AI does not invent clinical facts, does not replace deterministic safety checks, and must not be the sole mechanism for delivering critical alerts.

AI outputs may be incomplete or misinterpret ambiguous queries. Users must verify citations and defer to authoritative monographs, policies, and patient assessment.

Kill switches and non-AI fallback paths exist so workflows can continue when retrieval services are unavailable, subject to tenant configuration and clinical approval.

When connected to hospital systems, MedEazy depends on the accuracy, completeness, and timeliness of incoming data. Mapping errors, interface downtime, or partial feeds may limit checks or produce false negatives. Approved fail behavior must be configured and understood before production use.

MedEazy complements your EHR or hospital information system; it does not replace documentation, order entry, or dispensing verification in those systems unless explicitly integrated and approved for that workflow.

Stewardship queues, monitoring worklists, and utilization metrics are aids for program review. They are not benchmarks for individual clinician performance unless your governance committee explicitly approves such use with fair denominators and data quality disclosure.

Signals and suspected events require human confirmation before treating them as confirmed adverse drug reactions, medication errors, or incidents.

MedEazy is not an emergency response system. In medical emergencies, follow your institution’s emergency protocols and direct clinical assessment. Do not delay urgent care to consult the platform.

Formal intended-use labeling, classification, and regulatory status depend on deployment jurisdiction, feature scope, and independent regulatory assessment. Feature availability is tenant-authorized and deny-by-default until clinically and organizationally approved for each workflow.

This public disclaimer does not constitute regulatory clearance, CE marking, FDA authorization, or CDSCO registration unless explicitly stated in approved labeling for your deployment.

Use of MedEazy does not guarantee any particular clinical outcome, reduction in adverse events, or compliance with accreditation standards. Hospitals must validate workflows, train users, and monitor performance within their quality programs.